Pathology Laboratory Services

Serving more than 5,500 patients each day, Miraca Life Sciences is a leader in providing an academic-caliber clinical pathology laboratory with diagnostic services in the fields of dermatology, gastroenterology, hematology and urology. Building upon our experience with health IT, we also offer accessible EHR solutions to assist healthcare professionals as they work towards accordance with Meaningful Use initiatives.

Miraca Development Services focuses on providing specialty-specific, comprehensive pathology and laboratory services, as well as development and deployment services to pharmaceutical companies, contract research organizations, and diagnostic/molecular testing developers. A “one-stop shop” for all pathology and laboratory needs for clinical research and test validations, Miraca Development Services is the premier resource for lab testing, specialized pathology services, tissue procurement, and study design.

We employ a talented team of leading pathologists, histologists, lab technicians, technology consultants, and other medical professionals — all driven to help provide the highest and most up-to-date levels of diagnostic quality, enhanced workflow and practice solutions possible. It’s part of our commitment: not only to scientific excellence, but to you.

Pathology Research & Publications

Our skilled team of field-specific clinical pathologists, consultants and experts work diligently to stay at the forefront of the ever-changing landscape of a pathology laboratory and health IT. As part of this diligence, we work closely with one another to provide the highest quality, academic-based research and information possible.

Equip yourself with powerful information on specific conditions and diseases with Miraca Life Sciences. Learn More
Explore the growing library of Miraca Life Sciences webinars and discover expertise in motion. Learn More

Recent News

Research Presented at USCAP 2015

March 27, 2015 — In Boston at the 2015 Annual Meeting of the United States & Canadian Academy of Pathology, several presentations included co-authors from Miraca Life Sciences’ urologic pathology team.

A poster titled “Predictive Value of ERG Oncoprotein Expression and Pathologic Parameters In the Stratification of Prostate Cancer Risk Associated With High Grade Prostatic Intraepithelial Neoplasia (HGPIN) Diagnosis In Prostate Needle [...]

Presentation at AAD National Meeting

March 21, 2015 — In San Francisco at the Annual Meeting of the American Academy of Dermatology, an electronic poster was presented, titled “Dermal Melanocytosis (Nevus of Ito) and Concurrent Cellular Neurothekeoma.”

This presentation was co-authored by Julie D.R. Reimann, MD, PhD, Director, Molecular Dermatopathology, at Miraca Life Sciences.

Featured Subspecialty Expert

Tadros  0072

Yousef Tadros, MD, FCAP, FASCP

Director of Uropathology Quality Assurance